Skip to content

Effect of Gluten-free Regimen on Ulcerative Colitis Patients

Effect of Gluten-free Regimen on the Quality of Life and Disease Severity of Ulcerative Colitis Patients; A Randomised Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190523043680N1
Enrollment
26
Registered
2019-06-15
Start date
2019-02-20
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis. Ulcerative colitis

Interventions

Intervention 1: Intervention group: The produced bread without gluten is sent to patients in the control group by the representative of the producer company (Sahar bread company). Nutritionists give c

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with at least 18 year-old of age who suffers from mild or moderate ulcerative colitis

Exclusion criteria

Exclusion criteria: Patients who suffering from severe type or inactive phase of ulcerative colitis Has a history of surgery due to IBD Using biological medications Those does not complete study protocol

Design outcomes

Primary

MeasureTime frame
Disease Severity. Timepoint: Disease severity is measured in two times . (at starting the study and ending of it which is after 6 weeks of receiving the regimen by patients). Method of measurement: With questionnaire of Simple Clinical Colitis Activity Index (SCCAI).;Quality of Life. Timepoint: Quality of life of patients is measured in two times . (at starting the study and ending of it which is after 6 weeks of receiving the regimen by patients). Method of measurement: With Persian version of IBD-Q.;Inflammation markers (ESR, CRP and Fecal Calprotectin). Timepoint: Inflammation markers of patients is measured in two times . (at starting the study and ending of it which is after 6 weeks of receiving the regimen by patients). Method of measurement: Routine laboratory methods.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Hadi

Tehran University of Medical Sciences

mynameisrezahadi@gmail.om+98 21 6658 1615

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026